FDA says Covid vaccines that target new variants won’t need large clinical trials to win approval – CNBC

The Food and Drug Administration said Monday that modified Covid-19 vaccines against new, emerging variants may be authorized without the need for lengthy clinical trials.
The new guidance, released… [read more]